Search results for: 'microbiom test'

The Top 50 Emerging Technologies research is a comprehensive analysis of the most disruptive technologies that will impact multiple industries, applications, and regions. This extraordinary and comprehensive research will deliver strategic guidance and actionable ideas on the hottest technologies that pack maximum potential to fuel global innovatio...

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

This research service analyzes the market for reference laboratories within the United States. The United States market was divided into the routine testing, esoteric testing, clinical trials testing, and anatomic pathology and cytology market segments.

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...

Identifying growth opportunities in the test & measurement industry beyond the existing business could bring about changes in the competitive landscape. It is no longer test equipment vs. test equipment: Manufacturers cannot focus on hardware alone. Instead, the potential exists for an entirely new services model that focuses on platforms and the e...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

03 Feb 2021  |  North America  |  Market Research

Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

Infographics

×

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

Partners in the autonomous driving value chain are on the brink of developing advanced driver-assistance systems (ADAS) and autonomous driving systems to enhance the safety and convenience requirements of the driver, passengers, and other vulnerable road users. Increasing automated safety requirements have necessitated the need for a robust regulat...

Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome...